Laboratory Of Stock Retained Earnings
| LH Stock | USD 252.87 1.44 0.57% |
Laboratory of fundamentals help investors to digest information that contributes to Laboratory's financial success or failures. It also enables traders to predict the movement of Laboratory Stock. The fundamental analysis module provides a way to measure Laboratory's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Laboratory stock.
Laboratory |
Laboratory of Company Retained Earnings Analysis
Laboratory's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Laboratory Retained Earnings | 7.89 B |
Most of Laboratory's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Laboratory of is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Laboratory of has a Retained Earnings of 7.89 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The retained earnings for all United States stocks is 15.45% higher than that of the company.
Laboratory Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Laboratory's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Laboratory could also be used in its relative valuation, which is a method of valuing Laboratory by comparing valuation metrics of similar companies.Laboratory is currently under evaluation in retained earnings category among its peers.
Laboratory Fundamentals
| Return On Equity | 0.0936 | ||||
| Return On Asset | 0.0405 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 26.59 B | ||||
| Shares Outstanding | 83.4 M | ||||
| Shares Owned By Insiders | 0.52 % | ||||
| Shares Owned By Institutions | 96.22 % | ||||
| Number Of Shares Shorted | 1.9 M | ||||
| Price To Earning | 12.69 X | ||||
| Price To Book | 2.59 X | ||||
| Price To Sales | 1.60 X | ||||
| Revenue | 12.16 B | ||||
| Gross Profit | 3.62 B | ||||
| EBITDA | 1.35 B | ||||
| Net Income | 379.2 M | ||||
| Cash And Equivalents | 430 M | ||||
| Cash Per Share | 4.63 X | ||||
| Total Debt | 5.95 B | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 1.73 X | ||||
| Book Value Per Share | 96.55 X | ||||
| Cash Flow From Operations | 1.33 B | ||||
| Short Ratio | 3.37 X | ||||
| Earnings Per Share | 8.84 X | ||||
| Price To Earnings To Growth | 0.51 X | ||||
| Target Price | 270.65 | ||||
| Number Of Employees | 70 K | ||||
| Beta | 1.05 | ||||
| Market Capitalization | 20.84 B | ||||
| Total Asset | 16.73 B | ||||
| Retained Earnings | 7.89 B | ||||
| Working Capital | 540.2 M | ||||
| Current Asset | 585.1 M | ||||
| Current Liabilities | 226.4 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 16.73 B | ||||
| Last Dividend Paid | 2.88 |
About Laboratory Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Laboratory of's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratory using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratory of based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Laboratory Piotroski F Score and Laboratory Altman Z Score analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.